A new study has found that Wegovy, an obesity drug produced by the multinational pharmaceutical company Novo Nordisk, is effective in preventing metabolic problems caused by weight gain in patients with human immunodeficiency virus (HIV)
And contaminated products carry real health risks including infection, immune reactions, and injection site complications
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. JAAOS, 2025
Comparison of 10 GLP-1 agonist medications There are several GLP-1 agonist medications on the market
are former employees and shareholders of AstraZeneca
The MHRA has approved these agents for specific indications, and NICE provides guidance on their use within the NHS